Role of urotensin II gene in genetic susceptibility to Type 2 diabetes mellitus in Japanese subjects
- 1 July 2003
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 46 (7) , 972-976
- https://doi.org/10.1007/s00125-003-1145-1
Abstract
Aim/Hypothesis Urotensin II is a potent vasoactive hormone and the urotensin II gene (UTS2) is localized to 1p36-p32, one of the regions reported to show possible linkage with Type 2 diabetes in Japanese subjects. The aim of this study is to investigate a possible contribution of SNPs in the UTS2 gene to the development of Type 2 diabetes. Methods We surveyed SNPs in the UTS2 gene in 152 Japanese subjects with Type 2 diabetes mellitus and two control Japanese cohorts: one consisting of 122 elderly subjects who met stringent criteria for being non-diabetic, including being older than 60 years of age with no evidence of diabetes (HbA1cp=0.0018) and subjects with normal glucose tolerance (p=0.0011), whereas the allele frequency of T21M was essentially identical in these three groups. Furthermore, in the subjects with normal glucose tolerance, 89N was associated with higher insulin concentrations on oral glucose tolerance test, suggesting reduced insulin sensitivity in subjects with 89N. Conclusion/interpretation These results strongly suggest that the S89N polymorphism in the UTS2 gene is associated with the development of Type 2 diabetes, via insulin sensitivity, in Japanese subjects.Keywords
This publication has 16 references indexed in Scilit:
- Molecular and pharmacological characterization of genes encoding urotensin‐II peptides and their cognate G‐protein‐coupled receptors from the mouse and monkeyBritish Journal of Pharmacology, 2002
- Genome-Wide Search for Type 2 Diabetes in Japanese Affected Sib-Pairs Confirms Susceptibility Genes on 3q, 15q, and 20q and Identifies Two New Candidate Loci on 7p and 11pDiabetes, 2002
- Urotensin II evokes potent vasoconstriction in humans in vivoBritish Journal of Pharmacology, 2002
- Insulin resistance and vascular functionJournal of Diabetes and its Complications, 2002
- Inhibition of Insulin Release by Urotensin II - A Study on the Perfused Rat PancreasHormone and Metabolic Research, 2001
- Human Urotensin-II, the Most Potent Mammalian Vasoconstrictor Identified To Date, as a Therapeutic Target for the Management of Cardiovascular DiseaseTrends in Cardiovascular Medicine, 2000
- Human urotensin‐II is an endothelium‐dependent vasodilator in rat small arteriesBritish Journal of Pharmacology, 2000
- Identification of Urotensin II as the Endogenous Ligand for the Orphan G-Protein-Coupled Receptor GPR14Biochemical and Biophysical Research Communications, 1999
- Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14Nature, 1999
- Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.Diabetes Care, 1999